Yuan et al. discovered that artemisinin inhibited neutrophil infiltration in rosacea-like mice and suppressed the activation of the NF-κB pathway, thus suggesting that artemisinin may improve chronic inflammatory skin diseases of the face by modulating immune response and angiogenesis [40]. This evidence concerns the gene NFKB1 and rosacea.